Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025

June 27, 2024

https://www.prnewswire.com/news-releases/insmed-announces-redemption-of-all-225-million-of-outstanding-1-75-convertible-senior-notes-due-2025–302183645.html

BRIDGEWATER, N.J., June 27, 2024 /PRNewswire/ — Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it has called all $225 million aggregate principal amount of its outstanding 1.75% Convertible Senior Notes Due 2025 (the “Notes”) (CUSIP No. 457669AA7) for redemption on August 9, 2024 (the “Redemption Date”). Insmed is redeeming the Notes as permitted under Section 11.03 of the indenture governing the Notes (the “Indenture”).

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.